A federal judge has ruled in favor of the FDA and dismissed Mylan's (MYL -0.5%) suit against the agency relating to it's decision to withhold approval for the company to sell a generic version of Novartis' (NVS +0.4%) heart drug Diovan. The court said the FDA had not acted “capriciously” when it denied MYL exclusivity to market its version, furthermore, the company failed to show it suffered “irreparable harm” as a result,
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 1:30PM)
at Zacks.com (Fri, 8:33AM)
at Investor's Business Daily (Tue, 2:59PM)
at Investor's Business Daily (Mon, 2:59PM)
at Investor's Business Daily (Feb 2, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs